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Hollingsworth, PhD; Chi Lin, MD PhD; Chi Zhang, PhD; Yu Shi, PhD; Luke Krajewski, BS; Dandan Zheng, PhD
Department of Radiation Oncology - University of Nebraska Medical Center
Radiomics is a process that mines quantitative data from imaging techniques, including MRIs, CTs, and 
PET scans. In this study, radiomics is used to find associations between clinical factors such as the number 
of metastases in pancreatic ductal adenocarcinoma (PDAC) patients from their preoperative CT scans. 
PDAC patients have a five-year survival rate only barely above 10%. By the time of diagnosis over half of 
pancreatic cancers are metastasized, and when that is the case the five-year survival rate is only 3%. It is 
hypothesized that radiomics can help predict clinical factors such as the number of metastases in 
pancreatic patients. These predictions can lead to improved treatment plans by risk stratification. Patients 
with a higher risk of metastases would adopt more aggressive treatment than patients with lower risk. This 
study included 87 patients diagnosed with PDAC who consented to a Rapid Autopsy Program. Although 
results have not yet been processed, future work would include finishing developing a model to use to 
predict PDAC metastases. 
Background
Radiomics
• Process of mining medical images for quantitative data (Figure 1.)
• Gain features from high-throughput extraction to construct models
• Goals:
• Use predictive models alongside clinical practices
• Non-invasive and personalized medicine
• Longitudinal monitoring
Pancreatic ductal adenocarcinoma (PDAC)
• Most common type of pancreatic cancer 
• Treatment: surgical resection of tumor, if possible, followed by radiation and 
chemotherapy
• Prognosis: many patients are diagnosed late-stage and have a survival rate of about 1 
year on average 
Figure 1. Radiomic workflow including image acquisition, segmentation, feature 
extraction, feature selection, and model building.  
Background (cont.)
Scientific subtitle goes here
Results
Abstract
Summer Undergraduate Research Program
Clinical Data from PDAC Patients: (Figure 2)
• Average number of metastases per patient within cohort is 5
• Most patients had between 0-5 metastases (69 patients)
• Most patients were stage IV at diagnosis (60 patients)
• Most patients had between 1-400 survival days after diagnosis (67 patients)
Figure 2. Number of patients per number of metastases. 
Image Acquisition
• 87 patients with PDAC
• Abdominal and Pelvic CTs
Contouring
• Highlight pancreatic tumor on each CT slice to later extract features from this region of 
interest (Figure 3.)
• Programs used: Velocity for contour, 3D slicer for 3D model
Figure 3. CT image of PDAC patient with pink contour and 3D model
Materials and Methods
Feature Extraction
• 982 features extracted
• Examples: shape of tumor, intensity of tumor, smooth/rough
• Program used: Slicer Radiomics
Analysis
• Involves feature selection and modeling
• Use machine learning to identify significant features
• Usually about 3 – 15 features are selected
• 70% of data is used to make a model, 30% of data is used to test the model
• After adjustment of the model, it can be verified on new outside data
Feature Extraction Results
• Most features extracted were texture analysis 
features (Figure 4.)
• Texture feature categories included: 
Glcm, gldm, glrlm, glszm, ngtdm, etc.
• Often pancreatic cancer radiomic 
studies find texture features significant in 
prediction models
• 2,2,2 kernel size applied, and log and wavelet 
features extracted in Slicer Radiomics 
parameters
Figure 4. Pie chart of extracted feature 
categories.  
Materials and Methods (cont.)
Future Work
The next steps for the project include feature selection and model building. If radiomics 
would be able to predict metastases, it would be more cost-effective, easily accessible, 
and could be used for non-invasive prognosis and optimal treatment prediction. Our 
model could provide a quick way for clinicians to risk assess PDAC patients. 
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